Biden-era policies rescinded by Donald Trump could signal a significant shake-up in Medicare and Medicaid drug price reforms.
The second round of Medicare Part D price negotiations will feature two drugs familiar to rheumatologists — Ofev and Otezla — ...
Right now, the biggest chipmaker in the world is facing massive tariffs in the US. The G5 will be Google's first Tensor chip ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback